2.1101
price down icon23.92%   -0.6699
 
loading
Canopy Growth Corporation stock is traded at $2.1101, with a volume of 15.21M. It is down -23.92% in the last 24 hours and down -26.31% over the past month. Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$2.78
Open:
$2.13
24h Volume:
15.21M
Relative Volume:
2.30
Market Cap:
$340.26M
Revenue:
$211.87M
Net Income/Loss:
$-551.61M
P/E Ratio:
-0.3092
EPS:
-6.8241
Net Cash Flow:
$-140.45M
1W Performance:
+6.28%
1M Performance:
-26.31%
6M Performance:
-66.90%
1Y Performance:
-51.04%
1-Day Range:
Value
$2.10
$2.33
1-Week Range:
Value
$1.85
$2.90
52-Week Range:
Value
$1.85
$14.92

Canopy Growth Corporation Stock (CGC) Company Profile

Name
Name
Canopy Growth Corporation
Name
Phone
855-558-9333
Name
Address
1 Hershey Drive, Smiths Falls, ON
Name
Employee
2,000
Name
Twitter
@CanopyGrowth
Name
Next Earnings Date
2025-02-07
Name
Latest SEC Filings
Name
CGC's Discussions on Twitter

Compare CGC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CGC
Canopy Growth Corporation
2.1101 340.26M 211.87M -551.61M -140.45M -6.8241
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
172.69 78.56B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.56 43.15B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.555 43.00B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.88 19.59B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
124.15 15.24B 2.24B 385.90M 440.10M 3.73

Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-04-23 Upgrade Bernstein Underperform → Mkt Perform
Nov-02-22 Initiated Bernstein Underperform
Oct-26-22 Upgrade Canaccord Genuity Sell → Hold
Jun-08-22 Downgrade BMO Capital Markets Market Perform → Underperform
Mar-22-22 Downgrade Barclays Equal Weight → Underweight
Dec-22-21 Downgrade BofA Securities Neutral → Underperform
Dec-20-21 Downgrade Piper Sandler Neutral → Underweight
Dec-07-21 Initiated Wells Fargo Underweight
Nov-18-21 Initiated Barclays Equal Weight
Nov-08-21 Downgrade CIBC Neutral → Sector Underperform
Nov-08-21 Downgrade Canaccord Genuity Hold → Sell
Nov-08-21 Downgrade Cowen Outperform → Market Perform
Oct-01-21 Downgrade BofA Securities Buy → Neutral
Aug-12-21 Upgrade Jefferies Underperform → Hold
Jun-02-21 Upgrade Canaccord Genuity Sell → Hold
May-25-21 Upgrade MKM Partners Neutral → Buy
Apr-28-21 Resumed BofA Securities Buy
Feb-24-21 Downgrade Jefferies Hold → Underperform
Feb-10-21 Downgrade Canaccord Genuity Hold → Sell
Feb-10-21 Downgrade The Benchmark Company Buy → Hold
Feb-05-21 Downgrade Piper Sandler Overweight → Neutral
Sep-04-20 Upgrade CFRA Buy → Strong Buy
Jun-01-20 Downgrade BMO Capital Markets Outperform → Market Perform
Jun-01-20 Downgrade Bryan Garnier Neutral → Sell
Jun-01-20 Downgrade CIBC Sector Outperform → Neutral
Jun-01-20 Downgrade Ladenburg Thalmann Buy → Neutral
Jun-01-20 Downgrade Stifel Buy → Sell
May-22-20 Resumed BofA/Merrill Buy
Apr-16-20 Upgrade Jefferies Underperform → Hold
Jan-28-20 Upgrade BMO Capital Markets Market Perform → Outperform
Dec-12-19 Reiterated Cantor Fitzgerald Neutral
Nov-20-19 Upgrade BofA/Merrill Neutral → Buy
Nov-15-19 Downgrade Alliance Global Partners Buy → Neutral
Nov-05-19 Initiated Cantor Fitzgerald Neutral
Oct-14-19 Downgrade Seaport Global Securities Buy → Neutral
Oct-11-19 Downgrade Jefferies Hold → Underperform
Sep-27-19 Downgrade BofA/Merrill Buy → Neutral
Sep-20-19 Initiated MKM Partners Neutral
Sep-18-19 Initiated Oppenheimer Perform
Aug-26-19 Upgrade Seaport Global Securities Neutral → Buy
Jul-17-19 Initiated Ladenburg Thalmann Buy
View All

Canopy Growth Corporation Stock (CGC) Latest News

pulisher
10:22 AM

Canopy Growth Corporation - Baystreet.ca

10:22 AM
pulisher
10:05 AM

Why Is Canada-Based Cannabis Firm Canopy Growth Stock Trading Lower On Friday? - Benzinga India

10:05 AM
pulisher
09:37 AM

Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates - MSN

09:37 AM
pulisher
09:26 AM

Canopy Growth stock tumbles as quarterly loss exceeds estimates - Proactive Investors USA

09:26 AM
pulisher
09:01 AM

Canopy Growth Q3 25 Earnings Conference Call At 10:00 AM ET - Nasdaq

09:01 AM
pulisher
08:27 AM

Canopy Growth reports $121.9-million quarterly loss compared with $216.8-million drop a year earlier - The Globe and Mail

08:27 AM
pulisher
08:23 AM

Small caps to watch: A wild week for pot stocks - The Globe and Mail

08:23 AM
pulisher
08:20 AM

Canopy Growth reports $121.9M Q3 loss compared with $216.8M loss a year earlier - Yahoo Canada Finance

08:20 AM
pulisher
08:15 AM

Canopy Growth’s mixed results stop momentum from recent marijuana-stock rally - MarketWatch

08:15 AM
pulisher
07:56 AM

Canopy Growth Corp Reports Q3 Revenue of $74.76 Million, Surpassing Estimates; EPS Details Not Provided - GuruFocus.com

07:56 AM
pulisher
07:51 AM

Canopy Growth (CGC) Misses Q3 EPS by 73c - StreetInsider.com

07:51 AM
pulisher
07:44 AM

Canopy Growth Shows Strong Product Performance and Financial Improvements in Q3 FY2025 - TipRanks

07:44 AM
pulisher
07:37 AM

Canopy Growth stock drops after Q3 results (CGC:NASDAQ) - Seeking Alpha

07:37 AM
pulisher
07:30 AM

Canopy Gwth Q3 Earnings Assessment - Benzinga

07:30 AM
pulisher
07:04 AM

Canopy Growth (CGC) Misses Q3 EPS by 63c - StreetInsider.com

07:04 AM
pulisher
07:00 AM

Canopy Growth Reports Third Quarter Fiscal Year 2025 Financial Results - PR Newswire

07:00 AM
pulisher
12:43 PM

Canopy Growth (CGC) Projected to Post Quarterly Earnings on Friday - MarketBeat

12:43 PM
pulisher
Feb 06, 2025

Canopy Growth (TSE:WEED) Reaches New 12-Month LowHere's What Happened - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Canopy Growth Target of Unusually High Options Trading (NASDAQ:CGC) - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Pot Stock Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Continues Gains Ahead of Earnings - Investorideas.com newswire

Feb 06, 2025
pulisher
Feb 06, 2025

Canopy Growth: Still A Disaster Heading Into Fiscal Q3 Results (NASDAQ:CGC) - Seeking Alpha

Feb 06, 2025
pulisher
Feb 06, 2025

Which Cannabis Stock Offers the Best Upside? Analysts Weigh In After ACB’s Rally - PUNE.NEWS

Feb 06, 2025
pulisher
Feb 06, 2025

Hemp Fiber Market Projected To Witness Substantial Growth, 2025-2032 | Hemp Tech, Tilray, Canopy Growth - EIN News

Feb 06, 2025
pulisher
Feb 05, 2025

Aurora Cannabis stock rises on Q3 beat rallying peers (ACB) - Seeking Alpha

Feb 05, 2025
pulisher
Feb 05, 2025

Canopy Growth (CGC) Stock Surges Over 5% Amid Earnings Report - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Spikes on Earnings Expectations - Investorideas.com newswire

Feb 05, 2025
pulisher
Feb 05, 2025

Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos? - Benzinga

Feb 05, 2025
pulisher
Feb 04, 2025

Promising Cannabis Stocks To Keep An Eye OnFebruary 02nd - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Best Cannabis Stocks To Add to Your WatchlistFebruary 01st - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Canopy Growth Corporation (CGC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Canopy Growth Takes a Big Step in Advancing Its Strategy for the U.S. Marijuana Market - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Canopy Growth (CGC) Expected to Announce Earnings on Friday - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Canopy Growth (TSE:WEED) Reaches New 52-Week LowTime to Sell? - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

Promising Cannabis Stocks To ConsiderJanuary 31st - MarketBeat

Jan 31, 2025
pulisher
Jan 31, 2025

Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts - MSN

Jan 31, 2025
pulisher
Jan 31, 2025

Martha Stewart Aligns with Canopy Growth in New CBD Partnership - Investopedia

Jan 31, 2025
pulisher
Jan 31, 2025

Canopy Growth (CGC) Projected to Post Earnings on Friday - Defense World

Jan 31, 2025
pulisher
Jan 30, 2025

Canopy Growth (CGC) Stock Drops Amid Financial Concerns - GuruFocus.com

Jan 30, 2025
pulisher
Jan 30, 2025

Cannabis Stocks To Keep An Eye OnJanuary 30th - MarketBeat

Jan 30, 2025
pulisher
Jan 29, 2025

Can Canada Maintain Its Cannabis Edge After Trudeau's Departure? - Benzinga

Jan 29, 2025
pulisher
Jan 27, 2025

Canopy Growth (TSE:WEED) Hits New 12-Month LowHere's What Happened - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Glow LifeTech Strengthens Board with Former Canopy Growth Retail Strategy Director - StockTitan

Jan 27, 2025
pulisher
Jan 27, 2025

Cannabis Beverage Market Poised To Witness Rapid Expansion, 2025-2032 | Aurora Cannabis., Aphria Inc., Canopy - EIN News

Jan 27, 2025
pulisher
Jan 25, 2025

Canopy Growth Prepares For Q3 2025 Financial Results - Evrim Ağacı

Jan 25, 2025
pulisher
Jan 25, 2025

Canopy Growth Corporation (CGC) Rises As Market Takes a Dip: Key Facts - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Stocks In Play: Canopy Growth Corporation - Barchart

Jan 24, 2025
pulisher
Jan 24, 2025

The Week In Cannabis: Trump's DEA Pick, Tyson's Reform Push, Dutch Coffee Shop Crisis And More - Benzinga

Jan 24, 2025

Canopy Growth Corporation Stock (CGC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$31.36
price down icon 0.19%
$11.88
price down icon 0.86%
$90.91
price down icon 0.14%
$10.81
price down icon 0.73%
$127.09
price down icon 0.03%
$124.94
price down icon 16.85%
Cap:     |  Volume (24h):